Status:
COMPLETED
Observational Study in COVID-19 Patients Treated With Remdesivir
Lead Sponsor:
Fadoi Foundation, Italy
Conditions:
Hospitalization
Eligibility:
All Genders
18+ years
Brief Summary
Taking into account the high number of COVID-19 patients managed in Italian Internal Medicine, Fadoi Foundation (Italian Scientific Society of Internal Medicine) promotes a national retrospective obse...
Detailed Description
This is a multicenter observational, retrospective study, which involves the participation of 35 Nationally Representative Internal Medicine Units, for each center data on all patients suffering from ...
Eligibility Criteria
Inclusion
- patients aged ≥ 18 years
- diagnosed with radiologically documented SARS-CoV-2 pneumonia
- treated with Remdesivir (according to the criteria defined by AIFA\*)
- admitted to Internal Medicine from March 2020 to August 2021.
Exclusion
- none
Key Trial Info
Start Date :
November 24 2021
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
June 30 2022
Estimated Enrollment :
1004 Patients enrolled
Trial Details
Trial ID
NCT05239988
Start Date
November 24 2021
End Date
June 30 2022
Last Update
February 28 2024
Active Locations (30)
Enter a location and click search to find clinical trials sorted by distance.
1
Ospedale "Mons. Giovanni Galliano"
Acqui Terme, (AL), Italy
2
Ente Ecclesiastico "F. Miulli"
Acquaviva delle Fonti, (BA), Italy
3
Ospedale di Andria
Andria, (BT), Italy
4
P.O. di Garbagnate
Garbagnate Milanese, (MI), Italy